approval
saveLINZESS (LINACLOTIDE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalLINZESS (LINACLOTIDE) — FDA approvalNov 4, 2025 · 336d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJun 12, 2023 · 1212d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalAug 24, 2021 · 1869d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalApr 12, 2021 · 2003d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalMar 8, 2017 · 3499d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJan 25, 2017 · 3541d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJan 6, 2017 · 3560d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalAug 31, 2016 · 3688d ago
same company · ±60 days · 6
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalOct 16, 2020
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalOct 16, 2020
- approvaldexamethasone LA: OZURDEX (DEXAMETHASONE) — FDA approvalOct 21, 2020
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalAug 7, 2020
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalAug 7, 2020
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalNov 19, 2020
comments(0)
5-min edit window · permanent after that